Acquired cancer tyrosine kinase inhibitor resistance: ROS as critical determinants

CC BY 4.0 UnportedBekeschus, Sander2023-05-222023-05-222021https://oa.tib.eu/renate/handle/123456789/12156http://dx.doi.org/10.34657/11189[No abstract available]enghttps://creativecommons.org/licenses/by/4.0610Carcinoma, Non-Small-Cell LungHumansLung NeoplasmsProtein Kinase InhibitorsReactive Oxygen SpeciesAcquired cancer tyrosine kinase inhibitor resistance: ROS as critical determinantsArticle